Article

miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response

Stress and Cancer Laboratory, Institut Curie, Paris, France.
Nature medicine (Impact Factor: 28.05). 11/2011; 17(12):1627-35. DOI: 10.1038/nm.2512
Source: PubMed

ABSTRACT Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials.

Download full-text

Full-text

Available from: Fatima Mechta-Grigoriou, Jun 30, 2015
1 Follower
 · 
276 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Prenatal exposure to diethylstilbestrol (DES) is known to cause increased susceptibility to a wide array of clinical disorders in humans. Previous studies from our laboratory demonstrated that prenatal exposure to DES induces thymic atrophy and apoptosis in thymus. In the current study, we investigated if such effects on the thymus result from alterations in the expression of microRNA (miR). To that end, we exposed pregnant C57BL/6 mice to DES, and miR profiles were studied in thymocytes of both the mother and fetuses on postnatal day 3 (GD17). Of the 609 mouse miRs examined by performing high-throughput miR arrays, we observed that there were 59 miRs that were altered that were common for both mothers and fetuses, whereas there were 107 miRs that were altered, specific to mothers only, and 101 miRs that were altered specific to fetuses only. Upon further analyses in the fetuses, we observed that DES-mediated changes in miRs expression may regulate genes involved in important functions such as apoptosis, autophagy, toxicity, and cancer. Of the miRs that showed decreased expression following DES treatment, miR-18b and miR-23a were found to possess complementary sequences and binding affinity for 3'UTR regions of Fas ligand (FasL) and Fas, respectively. Transfection studies confirmed that DES-mediated down-regulation of miR-18b and miR-23a led to increased expression of FasL and Fas. These data demonstrated that prenatal exposure to DES can cause alterations in miRs leading to changes in the expression of genes, specifically, miR-mediated increased expression in Fas and FasL causing apoptosis and thymic atrophy. The American Society for Pharmacology and Experimental Therapeutics.
    Molecular pharmacology 03/2015; 87(5). DOI:10.1124/mol.114.096743 · 4.12 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Compelling evidence show that Reactive Oxygen Species (ROS) levels are finely regulated in the cell and can act as "second messengers" in response to diverse stimuli. In tumor epithelial cells, ROS accumulate abnormally and induce signaling cascades that mediate the oncogenic phenotype. In addition to their impact on tumor epithelial cells, ROS also affect the surrounding cells that constitute the tumor microenvironment. Indeed, ROS production increases tumor angiogenesis, drives the onset of inflammation and promotes conversion of fibroblast into myofibroblasts. These cells, initially identified upon wound healing, exhibit similar properties to those observed in fibroblasts associated with aggressive adenocarcinomas. Indeed, analyses of tumors with distinct severity revealed the existence of multiple distinct co-existing subtypes of Carcinoma-Associated Fibroblasts (CAFs), with specific marker protein profiling. Chronic oxidative stress deeply modifies the proportion of these different fibroblast subtypes, further supporting tumor growth and metastatic dissemination. At last, ROS have been implicated in the metabolic reprogramming of both cancer cells and CAFs, allowing an adaptation to oxidative stress that ultimately promotes tumorigenesis and chemoresistance. In this review, we discuss the role of ROS in cancer cells and CAFs and their impact on tumor initiation, progression and metastasis.
    Seminars in Cancer Biology 01/2014; DOI:10.1016/j.semcancer.2013.12.007 · 9.33 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The p38 MAPK pathway is an important regulator of many cellular responses. It is well established that p38 MAPK signalling negatively regulates epithelial cell transformation, but enhanced p38 MAPK activity has been also correlated with bad clinical prognosis in some tumour types. Here, we provide genetic and pharmacological evidence showing that p38 MAPK inhibition cooperates with the chemotherapeutic agent cisplatin to kill tumour cells. We show that p38 MAPK inhibition results in ROS upregulation, which in turn activates the JNK pathway via inactivation of phosphatases, sensitizing human tumour cells to cisplatin-induced apoptosis. Using a mouse model for breast cancer, we confirm that inhibition of p38 MAPK cooperates with cisplatin treatment to reduce tumour size and malignancy in vivo. Taken together, our results illustrate a new function of p38 MAPK that helps tumour cells to survive chemotherapeutic drug treatments, and reveal that the combination of p38 MAPK inhibitors with cisplatin can be potentially exploited for cancer therapy.
    EMBO Molecular Medicine 11/2013; 5(11). DOI:10.1002/emmm.201302732 · 8.25 Impact Factor